African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 11, No. 4, April 2025 | pp. 289-300

DOI: 10.46882/AJIDR/148725

Article Type: Research Article

Title: Prevalence and macrolide resistance mutations of Mycoplasma pneumoniae in community-acquired atypical pneumonia

Names of Authors: Seung-Ho Lee¹*, Nadia Benjelloun², Patrick O'Sullivan³

Authors’ Affiliations: ¹Department of Internal Medicine, Korea University, Seoul, South Korea. ²Department of Microbiology, Ibn Tofail University, Kenitra, Morocco. ³Department of Respiratory Medicine, University College Cork, Cork, Ireland.

Abstract: Mycoplasma pneumoniae is a frequent cause of community-acquired respiratory tract infections in adolescents and young adults, with rising macrolide resistance complicating empirical therapy. In this study, we assessed the detection rate of M. pneumoniae and the prevalence of 23S rRNA point mutations conferring macrolide resistance. Throat swabs from 370 outpatients with radiologically confirmed atypical pneumonia were analyzed using real-time PCR and Sanger sequencing. M. pneumoniae DNA was detected in 23.5 percent of patients, and macrolide-resistant mutations—predominantly A2063G—were identified in 48.3 percent of positive specimens. Patients infected with resistant strains experienced significantly longer fever duration following initial azithromycin therapy. Rapid molecular resistance testing and timely switch to alternative doxycycline or fluoroquinolone regimens are recommended.

Keywords: Mycoplasma pneumoniae, Macrolide resistance, Atypical pneumonia, 23S rRNA mutation, Molecular diagnostics

Citation: Lee SH, Benjelloun N, O'Sullivan P (2025). Prevalence and macrolide resistance mutations of Mycoplasma pneumoniae in community-acquired atypical pneumonia. African Journal of Infectious Diseases Research, 11(4): 289–300. DOI: 10.46882/AJIDR/148725

Manuscript Timeline: Received: March 02, 2025; Revised: April 02, 2025; Accepted: April 18, 2025; Published: April 30, 2025